Replay - ReachX Biotech & Macro Panel - Where are we with Covid-19?

On June 4th we discussed Covid-19's scientific perspective and impact on Healthcare Systems and Capital Markets with ReachX Advisors Dr. Graham Schoelfield, Andrew Whelan, Benoit Anne and Dr. Sarah Oelsner

Main Topics:

Scientific Perspective:

• Where do we stand with the current development in fighting the pandemic?
• Which companies have promising approaches/ clinical trials ?

Healthcare Systems:

• What lessons can we derive from Covid-19 in terms of impact on the healthcare systems? (UK in particular)
• How will it affect health policies and healthcare investment?

Impact on Markets:

• Why the market performed so well over the past few weeks?
• How would you position yourself in the next few months?

The Panellists:

• Dr. Graham Schoelfield – Managing Partner at Scitaris, a consulting firm focused on R&D strategy for pharma and biotech firms. PhD in Biochemistry and Molecular Biology.

• Andrew Whelan – Strategic senior healthcare corporate finance expert and elderly care specialist. Founder and Chairman of Future Care Capital – a charity shaping thinking and practice in health and social care.

• Benoit Anne – Independent Senior market strategist with a specialization in tactical asset allocation, global macro and emerging markets. Most recently Head of Public Markets Strategy & Analytics with Liberty Mutual Investments in Boston.

• Dr. Sarah Oelsner – Managing Partner at Scitaris,  a consulting firm focused on R&D strategy for pharma and biotech firms. PhD in Immunology.